Form 4: NeuroOne Medical Technologies Executive Mark Christianson Reports Stock Disposal
SEC Form 4 Filing
Mark Christianson, Business Development Director at NeuroOne Medical Technologies, disposed of 343 shares of common stock to cover tax obligations.
Summary
- On September 30, 2024, Mark Christianson, the Business Development Director of NeuroOne Medical Technologies Corp, disposed of 343 shares of common stock.
- The transaction was executed at a price of $0.99 per share.
- Following the transaction, Christianson directly owns 294,169 shares of NeuroOne Medical Technologies Corp.
- The transaction was reported on October 2, 2024.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing simply reports a transaction. The disposal of shares to cover tax obligations is a routine event.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor potential alignment or misalignment of interests between management and shareholders.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a small disposal of shares by an executive.
Key Dates
| Date | Description |
|---|---|
| 09/30/2024 | Date of stock disposal transaction |
| 10/02/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.